Search Job Title Only
News By Subject
News by Disease
News By Date
Get Our FREE
) Bags Irish Software Developer
for $50 Million
12/11/2013 6:54:33 AM
San Diego scientific software developer Accelrys (NASDAQ: ACCL) says it has paid about $50 million in cash to acquire Qumas, an Irish specialist in compliance and quality management software.
The aquisition marks the fifth deal for Accelrys over the past two years, beginning with its $35 million buyout of Hopkinton, MA-based VelQuest and $30 million acquisition of Lafayette, CO-based Aegis Analytical Corp. in 2012. Accelrys bought the Swiss biosciences software company Vialis for $5 million and Fairfield, CA-based ChemSW for $15.3 million earlier this year.
Help employers find you! Check out all the
post your resume
(ACCL) Advances Biology Innovation With New Release of Assay and Study Management Product Suite
(NVS) May Swap Animal Health Assets Instead Of A Sale
(ACCL) Chops 12 Pct. of Workforce
(NVS) CEO Says Can Spend $4-6 Billion A Year On Buys To Strengthen Core Pharma
(ACCL) Offers Novel, Integrated Predictive Sciences Solutions Enabling Faster, More Cost-effective Innovation for Life Sciences Organizations
Savient Pharmaceuticals, Inc.
(SVNT) Agrees To Unload All Assets To
For $120.4 Million
Leading Biopharmaceutical Company Chooses Cloud-Based
ComplianceSP On SharePoint 2010 To Manage Content For Regulatory Submissions
The Medicines Company
In Deal Worth $474 Million
SharePoint 2010 to Manage Quality Across the Organization
(SAN.PA) Eyes $2.7 Billion In Buys Per Year: CEO
comments powered by Disqus.
comments powered by
Biotech/Pharma - Mergers and Acquisitions
Biotech/Pharma - Software
Biotech/Pharma - Mergers and Acquisitions (World)
Biotech/Pharma - Software (World)